Transdermal iontophoretic delivery of apomorphine in patients improved by surfactant formulation pretreatment
- 2 November 2004
- journal article
- clinical trial
- Published by Elsevier in Journal of Controlled Release
- Vol. 101 (1-3) , 199-208
- https://doi.org/10.1016/j.jconrel.2004.09.011
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Apomorphine in the Treatment of Parkinsonʼs DiseaseJournal of Neuroscience Nursing, 2001
- Apomorphine: An underutilized therapy for Parkinson's diseaseMovement Disorders, 2000
- Pharmacokinetic-Pharmacodynamic Relationships of Apomorphine in Patients with Parkinson??s DiseaseClinical Pharmacokinetics, 1999
- Subcutaneous apomorphine in late stage Parkinson's disease: a long term follow upJournal of Neurology, Neurosurgery & Psychiatry, 1998
- A double‐blind, placebo‐controlled study of intranasal apomorphine spray as a rescue agent for off‐states in Parkinson's diseaseMovement Disorders, 1998
- Pharmacokinetics and clinical efficacy of rectal apomorphine in patients with Parkinson's disease: A study of five different suppositoriesMovement Disorders, 1995
- Sublingual Apomorphine in Parkinsonʼs DiseaseClinical Neuropharmacology, 1991
- Absorption of apomorphine by various routes in parkinsonismMovement Disorders, 1991
- Peripheral pharmacokinetics of apomorphine in humansAnnals of Neurology, 1989
- Treatment of Parkinson's Disease with AporphinesNew England Journal of Medicine, 1976